Erik Sahai
Principal Group Leader - Assistant Research Director
Erik obtained his PhD with Richard Treisman in London studying RhoGTPases and their effectors. He then carried out post-doctoral work in both London (Chris Marshall) and New York (John Condeelis) before setting up his own group at the Cancer Research UK London Research Institute in 2004 (now part of the Francis Crick Institute).